WO2003048326A3 - Procedes et matieres associes a de nouveaux polypeptides et polynucleotides - Google Patents

Procedes et matieres associes a de nouveaux polypeptides et polynucleotides Download PDF

Info

Publication number
WO2003048326A3
WO2003048326A3 PCT/US2002/038526 US0238526W WO03048326A3 WO 2003048326 A3 WO2003048326 A3 WO 2003048326A3 US 0238526 W US0238526 W US 0238526W WO 03048326 A3 WO03048326 A3 WO 03048326A3
Authority
WO
WIPO (PCT)
Prior art keywords
polynucleotides
methods
polypeptides
novel polypeptides
materials relating
Prior art date
Application number
PCT/US2002/038526
Other languages
English (en)
Other versions
WO2003048326A2 (fr
Inventor
Malabika Ghosh
Y Tom Tang
Jian Rui Wang
Zhiwei Wang
Qing A Zhao
Chongjun Xu
Julio J Mulero
Bryan J Boyle
Original Assignee
Nuvelo Inc
Malabika Ghosh
Y Tom Tang
Jian Rui Wang
Zhiwei Wang
Qing A Zhao
Chongjun Xu
Julio J Mulero
Bryan J Boyle
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nuvelo Inc, Malabika Ghosh, Y Tom Tang, Jian Rui Wang, Zhiwei Wang, Qing A Zhao, Chongjun Xu, Julio J Mulero, Bryan J Boyle filed Critical Nuvelo Inc
Priority to US10/496,905 priority Critical patent/US20050192215A1/en
Priority to AU2002360460A priority patent/AU2002360460A1/en
Publication of WO2003048326A2 publication Critical patent/WO2003048326A2/fr
Priority to US10/758,846 priority patent/US20040248156A1/en
Publication of WO2003048326A3 publication Critical patent/WO2003048326A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

L'invention concerne des nouveaux polynucléotides et des polypeptides codés par lesdits polynucléotides ainsi que leurs mutants ou variants qui correspondent auxdits nouveaux polynucléotides et polypeptides. Dans d'autres modes de réalisation, l'invention concerne des procédés contenant des vecteurs pour produire des nouveaux polypeptides et des anticorps spécifiques pour lesdits polypeptides.
PCT/US2002/038526 2000-01-21 2002-12-02 Procedes et matieres associes a de nouveaux polypeptides et polynucleotides WO2003048326A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US10/496,905 US20050192215A1 (en) 2000-01-21 2002-12-02 Methods and materials relating to novel polypeptides and polynucleotides
AU2002360460A AU2002360460A1 (en) 2001-12-03 2002-12-02 Methods and materials relating to novel polypeptides and polynucleotides
US10/758,846 US20040248156A1 (en) 2001-12-03 2004-01-16 Methods and materials relating to novel C1q domain-containing polypeptides and polynucleotides

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US549901A 2001-12-03 2001-12-03
US10/005,499 2001-12-03

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US549901A Continuation-In-Part 2000-01-21 2001-12-03

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US10/758,846 Continuation-In-Part US20040248156A1 (en) 2001-12-03 2004-01-16 Methods and materials relating to novel C1q domain-containing polypeptides and polynucleotides

Publications (2)

Publication Number Publication Date
WO2003048326A2 WO2003048326A2 (fr) 2003-06-12
WO2003048326A3 true WO2003048326A3 (fr) 2004-12-02

Family

ID=21716182

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/038526 WO2003048326A2 (fr) 2000-01-21 2002-12-02 Procedes et matieres associes a de nouveaux polypeptides et polynucleotides

Country Status (2)

Country Link
AU (1) AU2002360460A1 (fr)
WO (1) WO2003048326A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003216525A1 (en) * 2002-03-28 2003-10-13 Eli Lilly And Company Novel secreted proteins and their uses
US7541340B2 (en) 2005-09-16 2009-06-02 Cornell Research Foundation, Inc. Methods for reducing CD36 expression
JP2009528820A (ja) * 2006-02-22 2009-08-13 フィロジェン・エッセペア 血管腫瘍マーカー
US20220324943A1 (en) * 2019-07-22 2022-10-13 University Of Florida Research Foundation, Incorporated Multimeric protein domains for multifunctionality and enhanced secretion of therapeutic proteins

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001057190A2 (fr) * 2000-02-03 2001-08-09 Hyseq, Inc. Acides nucleiques et polypeptides
WO2001075067A2 (fr) * 2000-03-31 2001-10-11 Hyseq, Inc. Nouveaux acides nucleiques et polypeptides

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001057190A2 (fr) * 2000-02-03 2001-08-09 Hyseq, Inc. Acides nucleiques et polypeptides
WO2001075067A2 (fr) * 2000-03-31 2001-10-11 Hyseq, Inc. Nouveaux acides nucleiques et polypeptides

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
DATABASE GENBANK [online] 2 November 2001 (2001-11-02), WALKE D.W. ET AL, XP002903285, Database accession no. (AX282843) *
DATABASE GENBANK [online] 2 November 2001 (2001-11-02), WALKE D.W. ET AL, XP002903286, Database accession no. (AX282833) *
DATABASE GENBANK [online] 6 November 2001 (2001-11-06), TANG Y.T. ET AL, XP002903287, Database accession no. (AAK52451) *
DATABASE GENBANK [online] 6 November 2001 (2001-11-06), TANG Y.T. ET AL, XP002903288, Database accession no. (AAK52452) *
DATABASE GENBANK [online] 6 November 2001 (2001-11-06), TANG Y.T. ET AL, XP002903289, Database accession no. (AAK51467) *
DATABASE GENBANK [online] 6 November 2001 (2001-11-06), TANG Y.T. ET AL, XP002903290, Database accession no. (AAM78334) *
DATABASE GENBANK [online] November 2001 (2001-11-01), WALKE D.W. ET AL, XP002903284, Database accession no. (AX282845) *

Also Published As

Publication number Publication date
AU2002360460A1 (en) 2003-06-17
AU2002360460A8 (en) 2003-06-17
WO2003048326A2 (fr) 2003-06-12

Similar Documents

Publication Publication Date Title
WO2005069854A3 (fr) Procedes et materiaux ayant trait a de nouveaux polypeptides et polynucleotides contenant le domaine c1q
WO2003054152A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2003025148A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2002070539A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2002081731A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2004080148A3 (fr) Nouveaux acides nucleiques et polypeptides
WO1999058562A3 (fr) Nouveaux composes
WO2003020894A3 (fr) Facteur de transcription lie a l'insuline et utilisations de celui-ci
WO1999055873A3 (fr) Polynucleotide(s) et polypeptides basb006 isoles a partir de neisseria meningites
WO2005091777A3 (fr) Procedes et matieres associes aux polypeptides de facteur de croissance semblable a l'insuline (igfl) et polynucleotides
WO2003029405A3 (fr) Procedes et materiaux relatifs aux polynucleotides et polypeptides de type facteur de croissance de cellules souches
WO2004007672A3 (fr) Procede et materiaux se rapportant a de nouveaux polypeptides et polynucleotides
MXPA03006218A (es) Receptor de citosina tipo 2 y acidos nucleicos que codifican para lo mismo.
WO2003048326A3 (fr) Procedes et matieres associes a de nouveaux polypeptides et polynucleotides
WO2003014297A3 (fr) Compositions et procedes relatifs a la famille multigenique biosynthetique de la daptomycine
WO2000078802A3 (fr) Polypeptides secretes et polynucleotides correspondants
WO2000004041A3 (fr) Procedes et materiaux associes a de nouveaux polypeptides semblables a cd39
WO2004039942A3 (fr) Procedes et materiaux associes a des polypeptides de type neurotrimine, et polynucleotides
GB9809683D0 (en) Novel compounds
AU4504999A (en) Novel compounds
GB9810285D0 (en) Novel compounds
WO2002077180A3 (fr) Nouveaux acides nucleiques et nouveaux polypeptides
WO2004111196A3 (fr) Mutants de la 2 b-1,6-n-acetylglycosaminyltransferase de nucleocapside
WO2002030971A3 (fr) Nouveaux composes
GB9812440D0 (en) Novel compounds

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 10496905

Country of ref document: US

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP